Loading...
Symbols:
Loading...
Symbols:
American Oriental Bioengineering Inc. (AOB)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on American Oriental Bioengineering Inc. (AOB)
45 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on AOB
- ChinaBio Today(23)
- SA Editor Miriam Metzinger(5)
- Microcap Speculator(4)
- Marc Gerstein(3)
- Ezra Marbach(2)
Most popular authors
(tracked in watchlists)
- Andrew Wilkinson(333)
- SA Editor Miriam Metzinger(116)
- Value Investor Insight(74)
- ChinaBio Today(61)
- Marc Gerstein(43)
Most commented on authors
- Glen Bradford(27)
- ChinaBio Today(23)
- Ezra Marbach(17)
- Microcap Speculator(15)
- Timothy Roe(7)
- China Biotech in Review: Earnings Week
- Why I Sold My China Positions
- American Oriental Books Another Solid Quarter
- Recessionary Equity Strategies: Having It All
- 100 Companies That Can Take Themselves Private
- Recessionary Equity Strategies: The Price Is Right
- China Bio in Review: Broad Themes and Deals
- Recessionary Equity Strategies: Flight to Quality
- American Oriental Announces Two Acquisitions
- Long Ideas for This Volatile Market
- China Biotech Week in Review: Earnings, Earnings, Earnings
- American Oriental Investors Unimpressed by Acquisition News
- 16 Stocks That Are Paying My College Tuition
- American Oriental Bioengineering: Prescription for Success?
- China Biotech Weekly Review
- American Oriental Prices Convertible Notes
- Investors Unimpressed by American Oriental Bioengineering Buyback Announcement
- China Biotech in Review: Broad Trends, Individual Companies
- American Oriental Generates Plenty of Financial Engineering News
- American Oriental Wants to Buyback $75 Million of Stock
- China Biotech Week in Review: Earnings, Deals and Drug Development
- American Oriental Sets Sights on Being China's Biggest Pharma
- China Biopharma: What’s Not to Like?
- American Oriental Reports Greatly Improved Q1
- The Long Case for American Oriental Bioengineering
- Biotech in Review: Positive Consolidation in China Life Science Companies
- American Oriental Still Intent on Expansion: Buys Stake in China Aoxing
- American Oriental Bioengineering Considering Several Acquisition Targets
- Thursday's Options Report: ANH, NLY, MER, WM, FNM, AOB, LCC, CMTR, JNPR, RCL
- Wednesday's Options Report: PDE, AOB, DirecTV, EWH, DDS
- American Oriental Bioengineering: Underwhelming Q3 Earnings
- American Oriental Bioengineering Completes Guangxi Boke Acquisition
- American Oriental Bioengineering: Ancient Secrets Meet Modern Medicine
- American Oriental Makes Another Plant-Based Healthcare Acquisition
- China Biotech Week In Review: Strategy Evolves For AstraZeneca
- Why Is American Oriental Bioengineering Resissuing Shares, Now?
- American Oriental Bioengineering Stirs Up Controversy
- American Oriental Acquires Rival Plant-based Drug Firm
- Dig into American Oriental Bioengineering
- Advanced Nutraceuticals: Fundamentals Gaining Strength (ANII, AOB, USNA, MTEX)
- The Good, The Bad, and The Ugly (ACRG, AOB, AVCA, HQSM, NMKT, PTLD, SMTX, TGB, VTEK)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »